Lung Cancer Screening Eligibility Assessment

NACompletedINTERVENTIONAL
Enrollment

6,125

Participants

Timeline

Start Date

July 31, 2023

Primary Completion Date

January 31, 2024

Study Completion Date

January 31, 2024

Conditions
Lung Cancer
Interventions
BEHAVIORAL

Framed Introductory Message A

Randomly assign patients to receive introductory message encouraging them to complete the survey (version A).

BEHAVIORAL

Framed Introductory Message B

Randomly assign patients to receive introductory message encouraging them to complete the survey (version B).

BEHAVIORAL

Framed Introductory Message C

Randomly assign patients to receive introductory message encouraging them to complete the survey (version C).

BEHAVIORAL

Framed Tobacco Use Message A

Randomly assign patients to receive norming message related to tobacco use (version A).

BEHAVIORAL

Framed Tobacco Use Message B

Randomly assign patients to receive norming message related to tobacco use (version B).

BEHAVIORAL

Financial Incentive

Randomly assigned patients to be entered into a drawing to receive a $100 gift card.

Trial Locations (1)

19104

University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Cancer Institute (NCI)

NIH

lead

Abramson Cancer Center at Penn Medicine

OTHER